搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yoqP (yoqP) CSB-YP516334BRJ
CSB-EP516334BRJ
CSB-BP516334BRJ
CSB-MP516334BRJ
CSB-EP516334BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yopK (yopK) CSB-YP516335BRJ
CSB-EP516335BRJ
CSB-BP516335BRJ
CSB-MP516335BRJ
CSB-EP516335BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yopF (yopF) CSB-YP516336BRJ
CSB-EP516336BRJ
CSB-BP516336BRJ
CSB-MP516336BRJ
CSB-EP516336BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yopA (yopA), partial CSB-YP516337BRJ1
CSB-EP516337BRJ1
CSB-BP516337BRJ1
CSB-MP516337BRJ1
CSB-EP516337BRJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized lipoprotein yonS (yonS) CSB-YP516338BRJ
CSB-EP516338BRJ
CSB-BP516338BRJ
CSB-MP516338BRJ
CSB-EP516338BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yonK (yonK) CSB-YP516339BRJ
CSB-EP516339BRJ
CSB-BP516339BRJ
CSB-MP516339BRJ
CSB-EP516339BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yonG (yonG) CSB-YP516340BRJ
CSB-EP516340BRJ
CSB-BP516340BRJ
CSB-MP516340BRJ
CSB-EP516340BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yomY (yomY) CSB-YP516341BRJ
CSB-EP516341BRJ
CSB-BP516341BRJ
CSB-MP516341BRJ
CSB-EP516341BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yomW (yomW) CSB-YP516342BRJ
CSB-EP516342BRJ
CSB-BP516342BRJ
CSB-MP516342BRJ
CSB-EP516342BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yomR (yomR) CSB-YP516343BRJ
CSB-EP516343BRJ
CSB-BP516343BRJ
CSB-MP516343BRJ
CSB-EP516343BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived recombinase-like protein yomM (yomM) CSB-YP516344BRJ
CSB-EP516344BRJ
CSB-BP516344BRJ
CSB-MP516344BRJ
CSB-EP516344BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yomH (yomH) CSB-YP516345BRJ
CSB-EP516345BRJ
CSB-BP516345BRJ
CSB-MP516345BRJ
CSB-EP516345BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis N-acetylmuramoyl-L-alanine amidase BlyA (blyA) CSB-YP516346BRJ
CSB-EP516346BRJ
CSB-BP516346BRJ
CSB-MP516346BRJ
CSB-EP516346BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yolF (yolF), partial CSB-YP516347BRJ
CSB-EP516347BRJ
CSB-BP516347BRJ
CSB-MP516347BRJ
CSB-EP516347BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yolA (yolA) CSB-YP516348BRJ
CSB-EP516348BRJ
CSB-BP516348BRJ
CSB-MP516348BRJ
CSB-EP516348BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yokH (yokH) CSB-YP516349BRJ
CSB-EP516349BRJ
CSB-BP516349BRJ
CSB-MP516349BRJ
CSB-EP516349BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis SPBc2 prophage-derived uncharacterized protein yokC (yokC) CSB-YP516350BRJ
CSB-EP516350BRJ
CSB-BP516350BRJ
CSB-MP516350BRJ
CSB-EP516350BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized protein ypzE (ypzE) CSB-YP516351BRJ
CSB-EP516351BRJ
CSB-BP516351BRJ
CSB-MP516351BRJ
CSB-EP516351BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized protein yqzG (yqzG) CSB-YP516352BRJ
CSB-EP516352BRJ
CSB-BP516352BRJ
CSB-MP516352BRJ
CSB-EP516352BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized protein yqzI (yqzI) CSB-YP516353BRJ
CSB-EP516353BRJ
CSB-BP516353BRJ
CSB-MP516353BRJ
CSB-EP516353BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>